Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents

Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents

US Patent 9827335 · Granted Nov 28, 2017

Estimated economic value: $23,205,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulated and/or co-formulated liposome compositions containing toll-like recep2025
Formulated and/or co-formulated liposome compositions containing IDO antagonist 2025
Population control using engineered translocations2025
DNA sequence modification-based gene drive2024
Formulated and/or co-formulated liposome compositions containing PD-1 antagonist2024
DNA sequence modification-based gene drive2024
Formulated and/or co-formulated liposome compositions containing toll-like recep2024
Chelate compounds2024
Formulated and/or co-formulated liposome compositions containing PD-1 antagonist2023
Formulated and/or co-formulated liposome compositions containing TFGB antagonist2023
Porous membranes with a polymer grafting, methods and uses thereof2023
Formulated and/or co-formulated liposome compositions containing toll-like recep2023